HQH Overview

Dividend Declaration: abrdn Healthcare Investors (HQH) has announced a quarterly dividend of $0.57 per share, payable on January 12, with shareholders of record on November 21.

Ex-Dividend Date: The ex-dividend date for the upcoming dividend is also set for November 21.

Performance Rating: HQH has been rated as severely underperforming compared to its peers, leading to a downgrade in its rating.

Investment Strategy: The commentary suggests an income approach to capitalize on the healthcare recovery, as indicated in abrdn Healthcare Investors' Q2 2025 commentary.

Dividend Opportunity: The article highlights a unique investment opportunity in the UK insurer Phoenix Group, which is pulling GBP22 billion from Aberdeen Group to manage funds in-house, presenting a 12%+ dividend yield in a struggling sector.

Aberdeen's Performance Issues: Aberdeen Group has faced poor performance and negative sentiment, particularly with its international closed-end funds, leading to a focus on two specific funds, abrdn Healthcare Investors (HQH) and abrdn Healthcare Opportunities Fund (THQ), which have shown better performance against benchmarks.

Investment Potential: HQH is noted for its deeper discount and better-performing portfolio compared to THQ, making it an attractive option for investors seeking dividends and potential capital gains as market sentiment around pharmaceuticals may improve.

Monthly Payout Preference: The author expresses a preference for funds that offer monthly payouts, which indicate management confidence, and suggests considering five top monthly dividend closed-end funds with a yield of 10.2% and potential for 20% capital gains.

Dividend Announcement: abrdn Healthcare Investors (NYSE: HQH) has declared a quarterly dividend of $0.51 per share, payable on September 30 to shareholders of record as of August 22, with an ex-dividend date also on August 22.

Investment Insights: The commentary highlights concerns regarding the high risk and low return associated with HQH's focus on biotech investments, while also noting its efficiency in generating income from healthcare.

Annual Meetings Held: Aberdeen Investments U.S. Closed-End Funds conducted their Annual Meeting of Shareholders on May 28, 2025, where various proposals were voted on by shareholders across multiple funds, including the election of directors and the continuation of terms for existing directors.

Voting Results: The meetings reported significant shareholder participation, with various candidates receiving majority votes for their respective positions, indicating strong support for the current governance structure within the funds.